Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech

Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech

Immune thrombocytopenia is an autoimmune disease that can cause bleeding in severe cases. Although available published data do not associate the BNT162b2 vaccine (Pfizer-BioNTech) with the risk of developing thrombocytopenia, the ChAdOx1 nCov-19 vaccine has raised concerns about its potential link w...

Full description

Bibliographic Details
Main Authors: Yusuke Okada, Ryota Sakai, Marie Sato-Fitoussi, Marika Nodera, Shoichi Yoshinaga, Akiko Shibata, Takahiko Kurasawa, Tsuneo Kondo, Koichi Amano
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
BNT162b2
COVID-19
hemorrhage
immune thrombocytopenia
rheumatoid arthritis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.751598/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.751598/full

Similar Items